These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Clinical study of the selective anxiolytic agent afobazol].
    Author: Neznamov GG, Siuniakov SA, Chumakov DV, Bochkarev VK, Seredenin SB.
    Journal: Eksp Klin Farmakol; 2001; 64(2):15-9. PubMed ID: 11548440.
    Abstract:
    A standard clinical trial including pharmaco-EEG investigation of the new selective anxiolytic afobazole was performed on a group of 30 patients with anxiety and anxious-asthenic disorders and premorbid individual asthenic profile traits. Afobazole exhibits the anxiolytic action with an activating component in the absence of sedative and myorelaxant effects. The clinical trial results confirmed good prospects of using the experimentally validated pharmacogenetic concept of anxioselectivity as a methodological approach to the design of new drugs possessing selective anxiolytic properties.
    [Abstract] [Full Text] [Related] [New Search]